Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,774 across all filing types
Latest filing 2019-06-24 M&A Activity
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
EVOTEC, SENSYNE HEALTH, THE UNIVERSITY OF OXFORD, OSI, AND OUI CREATE NEW BRIDGE PARTNERSHIP 'LAB10X' IN DIGITAL HEALTH
M&A Activity Classification · 99% confidence The document is a press release dated June 24, 2019, announcing a new strategic partnership ('LAB10x') between Evotec, Sensyne Health, the University of Oxford, and related entities to accelerate digital health solutions powered by AI. It details the terms of the agreement, funding, and strategic goals. This type of announcement, which details a significant business development, partnership, or strategic move, is typically classified as a general corporate news release. Since it is not a formal regulatory filing like a 10-K, an earnings release (ER), or a specific report (AR, IR), and it is not a simple announcement of a report publication (RPA), the most appropriate general category for significant corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), which serves as a broad category for miscellaneous announcements transmitted via services like DGAP/EQS.
2019-06-24 English
EVOTEC, SENSYNE HEALTH, THE UNIVERSITY OF OXFORD, OSI, AND OUI CREATE NEW BRIDGE PARTNERSHIP 'LAB10X' IN DIGITAL HEALTH
M&A Activity Classification · 99% confidence The document is a press release dated June 24, 2019, announcing a new strategic partnership ('LAB10x') between Evotec, Sensyne Health, the University of Oxford, and related entities to focus on digital health solutions using AI. The text uses keywords like 'DGAP-News', 'Alliance', 'announced today', and provides details about the structure, funding (£5 million over three years), and goals of the collaboration. This type of announcement, detailing a significant business development or strategic agreement, is best classified as a general corporate announcement or news release. Since there is no specific category for 'Strategic Partnership Announcement' and it is not a formal regulatory filing like 10-K, ER, or IR, the most appropriate fallback category is 'Regulatory Filings' (RNS), which serves as a general category for miscellaneous corporate news releases that don't fit elsewhere, especially when the content is primarily news-driven rather than a formal financial report or proxy material. The length (17k chars) confirms it is the full announcement, not just a brief notice of publication.
2019-06-24 German
RESOLUTIONS OF THE ANNUAL GENERAL MEETING 2019 OF EVOTEC SE
AGM Information Classification · 99% confidence The document is titled "RESOLUTIONS OF THE ANNUAL GENERAL MEETING 2019 OF EVOTEC SE" and explicitly mentions that shareholders approved all proposals at the Annual General Meeting (AGM). It details the election of a new Supervisory Board and resolutions passed during the meeting. This content directly relates to the proceedings and outcomes of an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (7446 chars) is substantial enough that it is likely the summary/results document itself, not just a brief announcement of publication (RPA/RNS).
2019-06-19 English
Evotec Hauptversammlung 2019
AGM Information Classification · 98% confidence The document text contains structured slides with headings like 'Begrüßung und Vorstellung' (Welcome and Introduction), 'DER AUFSICHTSRAT' (The Supervisory Board), 'DER VORSTAND' (The Management Board), and sections detailing 'Strategie', 'Plattform & Partner', and 'Finanzen – Rückblick & Ausblick'. It features extensive use of presentation graphics, charts, and bullet points typical of a corporate presentation given to shareholders or investors. The structure strongly suggests a formal presentation, likely accompanying or summarizing the annual results or strategy review. Given the context of reviewing strategy, financials, and management structure, this is characteristic of an Investor Presentation (IP) or materials presented at an Annual General Meeting (AGM-R). Since it is a detailed presentation deck covering strategy, pipeline, and financials, Investor Presentation (IP) is the most fitting primary classification, although it could also be AGM material. I will classify it as an Investor Presentation (IP) due to the depth of strategic and pipeline detail presented in a slide format.
2019-06-19 German
EVOTEC RECEIVES $ 23.8 M GRANT TO JOIN THE GLOBAL FIGHT AGAINST TUBERCULOSIS
Regulatory Filings Classification · 100% confidence The document is a press release dated June 10, 2019, announcing that Evotec SE received a $23.8 million grant from the Bill & Melinda Gates Foundation to fight tuberculosis. It details the purpose of the grant, the background on TB, and includes executive commentary. This type of announcement, which details a significant business development, partnership, or funding event, fits best under the 'Capital/Financing Update' (CAP) if it were purely about raising capital, or 'Regulatory Filings' (RNS) as a general news release. However, since it is a specific announcement about receiving a grant (a form of funding/financing for a project), 'CAP' is a possibility, but 'RNS' is often used for general, non-SEC mandated news releases that don't fit other specific categories like ER or DIV. Given the content is a news announcement about a grant/partnership, and it is disseminated via DGAP (a service for regulatory announcements), it is a general corporate news item. Since there is no specific category for 'Grant Announcement' or 'Partnership Announcement' that isn't financial restructuring, 'RNS' (Regulatory Filings / General Regulatory Announcements) is the most appropriate fallback for this type of corporate news release that is not an earnings release (ER) or a formal financial report (10-K, IR).
2019-06-10 English
EVOTEC AND CELGENE FURTHER EXPAND IPSC COLLABORATION INCLUDING NEW CELL TYPE
Regulatory Filings Classification · 95% confidence The document is a press release dated June 5, 2019, announcing an expansion of a strategic alliance between Evotec SE and Celgene Corporation, which triggered a $9.0M payment to Evotec. It discusses scientific progress (iPSC technology, neurodegenerative diseases) and includes standard corporate boilerplate, forward-looking statements, and contact information. This type of announcement, detailing a business development, partnership update, or milestone achievement that is not a core financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV), typically falls under general regulatory news or miscellaneous corporate updates. Since it is a specific business development announcement disseminated via DGAP (a service for Regulatory Announcements, Financial/Corporate News and Press Releases), and it doesn't fit the specific categories like M&A (TAR), Capital (CAP), or Earnings (ER), the most appropriate general category for significant, non-standard corporate news is Regulatory Filings (RNS), which serves as a broad category for such announcements.
2019-06-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.